HEADER TRANSFERASE/TRANSFERASE INHIBITOR 17-MAY-16 5K0X TITLE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TITLE 2 TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC2541 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE MER; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, UNP RESIDUES 570-864; COMPND 5 SYNONYM: PROTO-ONCOGENE C-MER,RECEPTOR TYROSINE KINASE MERTK; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MERTK, MER; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MACROCYCLIC, DRUG DESIGN, FIBRINOLYTIC AGENTS, PROTEIN KINASE KEYWDS 2 INHIBITORS, PROTO-ONCOGENE PROTEINS, PYRIMIDINES, RECEPTOR PROTEIN- KEYWDS 3 TYROSINE KINASES, STRUCTURE-ACTIVITY RELATIONSHIP, THROMBOSIS, KEYWDS 4 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.L.MCIVER,W.ZHANG,Q.LIU,X.JIANG,M.A.STASHKO,J.NICHOLS,M.J.MILEY, AUTHOR 2 J.NORRIS-DROUIN,M.MACHIUS,D.DERYCKERE,E.WOOD,D.K.GRAHAM,H.S.EARP, AUTHOR 3 D.KIREEV,S.V.FRYE,X.WANG REVDAT 2 27-SEP-23 5K0X 1 REMARK REVDAT 1 22-FEB-17 5K0X 0 JRNL AUTH A.L.MCIVER,W.ZHANG,Q.LIU,X.JIANG,M.A.STASHKO,J.NICHOLS, JRNL AUTH 2 M.J.MILEY,J.NORRIS-DROUIN,M.MACHIUS,D.DERYCKERE,E.WOOD, JRNL AUTH 3 D.K.GRAHAM,H.S.EARP,D.KIREEV,S.V.FRYE,X.WANG JRNL TITL DISCOVERY OF MACROCYCLIC PYRIMIDINES AS MERTK-SPECIFIC JRNL TITL 2 INHIBITORS. JRNL REF CHEMMEDCHEM V. 12 207 2017 JRNL REFN ESSN 1860-7187 JRNL PMID 28032464 JRNL DOI 10.1002/CMDC.201600589 REMARK 2 REMARK 2 RESOLUTION. 2.23 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.23 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.86 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 85.0 REMARK 3 NUMBER OF REFLECTIONS : 26319 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.600 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.8664 - 5.3645 1.00 2092 172 0.1818 0.1980 REMARK 3 2 5.3645 - 4.2629 1.00 2051 169 0.1524 0.1944 REMARK 3 3 4.2629 - 3.7255 1.00 2055 168 0.1629 0.2397 REMARK 3 4 3.7255 - 3.3855 1.00 2041 168 0.1829 0.2621 REMARK 3 5 3.3855 - 3.1432 1.00 2063 170 0.2070 0.2545 REMARK 3 6 3.1432 - 2.9581 1.00 2038 168 0.2068 0.2709 REMARK 3 7 2.9581 - 2.8101 1.00 2036 168 0.2137 0.2463 REMARK 3 8 2.8101 - 2.6879 0.98 1952 160 0.2084 0.2794 REMARK 3 9 2.6879 - 2.5845 0.91 1858 153 0.2029 0.2649 REMARK 3 10 2.5845 - 2.4953 0.80 1627 134 0.2084 0.2466 REMARK 3 11 2.4953 - 2.4174 0.72 1479 121 0.2021 0.2701 REMARK 3 12 2.4174 - 2.3483 0.62 1242 102 0.1903 0.2554 REMARK 3 13 2.3483 - 2.2865 0.51 1056 87 0.1786 0.2929 REMARK 3 14 2.2865 - 2.2307 0.36 729 60 0.1786 0.2758 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.630 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.014 4304 REMARK 3 ANGLE : 1.296 5813 REMARK 3 CHIRALITY : 0.059 647 REMARK 3 PLANARITY : 0.008 727 REMARK 3 DIHEDRAL : 15.038 2630 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5K0X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-MAY-16. REMARK 100 THE DEPOSITION ID IS D_1000220535. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : SI(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30743 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.230 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.23 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.66100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3BRB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN AT 32.5 MG/ML (IN 20 MM TRIS REMARK 280 PH 8.0, 500 MM NACL, 2MM BME) WAS INCUBATED OVERNIGHT WITH REMARK 280 INHIBITOR AT 2.5 MM FINAL CONCENTRATION, AND THEN WAS MIXED 1:1 REMARK 280 WITH CRYSTALLIZATION SOLUTION (27-33% (V/V) PEG 400, 200 MM REMARK 280 MGCL2, 100 MM TRIS PH 8.5)., VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 45.79950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 552 REMARK 465 GLY A 553 REMARK 465 SER A 554 REMARK 465 SER A 555 REMARK 465 HIS A 556 REMARK 465 HIS A 557 REMARK 465 HIS A 558 REMARK 465 HIS A 559 REMARK 465 HIS A 560 REMARK 465 HIS A 561 REMARK 465 SER A 562 REMARK 465 SER A 563 REMARK 465 GLY A 564 REMARK 465 LEU A 565 REMARK 465 VAL A 566 REMARK 465 PRO A 567 REMARK 465 ARG A 568 REMARK 465 GLY A 569 REMARK 465 SER A 570 REMARK 465 GLU A 571 REMARK 465 GLU A 572 REMARK 465 LEU A 573 REMARK 465 GLN A 574 REMARK 465 ASN A 575 REMARK 465 GLY A 596 REMARK 465 GLU A 597 REMARK 465 PHE A 598 REMARK 465 ARG A 629 REMARK 465 GLU A 630 REMARK 465 MET A 659 REMARK 465 SER A 660 REMARK 465 SER A 661 REMARK 465 GLN A 662 REMARK 465 GLY A 663 REMARK 465 ILE A 664 REMARK 465 LEU A 744 REMARK 465 SER A 745 REMARK 465 LYS A 746 REMARK 465 LYS A 747 REMARK 465 ILE A 748 REMARK 465 TYR A 749 REMARK 465 SER A 750 REMARK 465 GLY A 751 REMARK 465 ASP A 752 REMARK 465 TYR A 753 REMARK 465 TYR A 754 REMARK 465 ARG A 755 REMARK 465 GLN A 756 REMARK 465 GLY A 757 REMARK 465 ARG A 758 REMARK 465 ILE A 759 REMARK 465 ALA A 760 REMARK 465 LYS A 761 REMARK 465 MET A 762 REMARK 465 VAL A 864 REMARK 465 MET B 552 REMARK 465 GLY B 553 REMARK 465 SER B 554 REMARK 465 SER B 555 REMARK 465 HIS B 556 REMARK 465 HIS B 557 REMARK 465 HIS B 558 REMARK 465 HIS B 559 REMARK 465 HIS B 560 REMARK 465 HIS B 561 REMARK 465 SER B 562 REMARK 465 SER B 563 REMARK 465 GLY B 564 REMARK 465 LEU B 565 REMARK 465 VAL B 566 REMARK 465 PRO B 567 REMARK 465 ARG B 568 REMARK 465 GLY B 569 REMARK 465 SER B 570 REMARK 465 GLU B 571 REMARK 465 GLU B 572 REMARK 465 LEU B 573 REMARK 465 GLN B 574 REMARK 465 GLY B 596 REMARK 465 GLU B 597 REMARK 465 MET B 621 REMARK 465 LYS B 622 REMARK 465 LEU B 623 REMARK 465 ASP B 624 REMARK 465 ASN B 625 REMARK 465 SER B 626 REMARK 465 SER B 627 REMARK 465 GLN B 628 REMARK 465 ARG B 629 REMARK 465 GLU B 630 REMARK 465 ILE B 631 REMARK 465 GLU B 632 REMARK 465 PHE B 742 REMARK 465 GLY B 743 REMARK 465 LEU B 744 REMARK 465 SER B 745 REMARK 465 LYS B 746 REMARK 465 LYS B 747 REMARK 465 ILE B 748 REMARK 465 TYR B 749 REMARK 465 SER B 750 REMARK 465 GLY B 751 REMARK 465 ASP B 752 REMARK 465 TYR B 753 REMARK 465 TYR B 754 REMARK 465 ARG B 755 REMARK 465 GLN B 756 REMARK 465 GLY B 757 REMARK 465 ARG B 758 REMARK 465 ILE B 759 REMARK 465 ALA B 760 REMARK 465 LYS B 761 REMARK 465 MET B 762 REMARK 465 VAL B 864 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU A 689 HG1 THR A 690 1.57 REMARK 500 O ASP A 723 HD22 ASN A 728 1.57 REMARK 500 O ILE B 695 HH21 ARG B 796 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 687 NE - CZ - NH1 ANGL. DEV. = -4.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 627 -151.96 -109.22 REMARK 500 PHE A 634 -39.50 -150.90 REMARK 500 THR A 690 -41.97 83.54 REMARK 500 HIS A 694 130.60 -39.51 REMARK 500 ASP A 723 31.99 -150.88 REMARK 500 ASP A 774 -155.29 -87.49 REMARK 500 ARG A 775 29.93 -140.34 REMARK 500 LEU B 577 22.41 -74.96 REMARK 500 THR B 690 -35.26 98.26 REMARK 500 HIS B 694 132.82 -36.16 REMARK 500 ASP B 723 38.62 -154.03 REMARK 500 ALA B 773 -70.05 -86.75 REMARK 500 LEU B 826 142.30 -39.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue K0X A 904 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue K0X B 903 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5K0K RELATED DB: PDB DBREF 5K0X A 570 864 UNP Q12866 MERTK_HUMAN 570 864 DBREF 5K0X B 570 864 UNP Q12866 MERTK_HUMAN 570 864 SEQADV 5K0X MET A 552 UNP Q12866 INITIATING METHIONINE SEQADV 5K0X GLY A 553 UNP Q12866 EXPRESSION TAG SEQADV 5K0X SER A 554 UNP Q12866 EXPRESSION TAG SEQADV 5K0X SER A 555 UNP Q12866 EXPRESSION TAG SEQADV 5K0X HIS A 556 UNP Q12866 EXPRESSION TAG SEQADV 5K0X HIS A 557 UNP Q12866 EXPRESSION TAG SEQADV 5K0X HIS A 558 UNP Q12866 EXPRESSION TAG SEQADV 5K0X HIS A 559 UNP Q12866 EXPRESSION TAG SEQADV 5K0X HIS A 560 UNP Q12866 EXPRESSION TAG SEQADV 5K0X HIS A 561 UNP Q12866 EXPRESSION TAG SEQADV 5K0X SER A 562 UNP Q12866 EXPRESSION TAG SEQADV 5K0X SER A 563 UNP Q12866 EXPRESSION TAG SEQADV 5K0X GLY A 564 UNP Q12866 EXPRESSION TAG SEQADV 5K0X LEU A 565 UNP Q12866 EXPRESSION TAG SEQADV 5K0X VAL A 566 UNP Q12866 EXPRESSION TAG SEQADV 5K0X PRO A 567 UNP Q12866 EXPRESSION TAG SEQADV 5K0X ARG A 568 UNP Q12866 EXPRESSION TAG SEQADV 5K0X GLY A 569 UNP Q12866 EXPRESSION TAG SEQADV 5K0X MET B 552 UNP Q12866 INITIATING METHIONINE SEQADV 5K0X GLY B 553 UNP Q12866 EXPRESSION TAG SEQADV 5K0X SER B 554 UNP Q12866 EXPRESSION TAG SEQADV 5K0X SER B 555 UNP Q12866 EXPRESSION TAG SEQADV 5K0X HIS B 556 UNP Q12866 EXPRESSION TAG SEQADV 5K0X HIS B 557 UNP Q12866 EXPRESSION TAG SEQADV 5K0X HIS B 558 UNP Q12866 EXPRESSION TAG SEQADV 5K0X HIS B 559 UNP Q12866 EXPRESSION TAG SEQADV 5K0X HIS B 560 UNP Q12866 EXPRESSION TAG SEQADV 5K0X HIS B 561 UNP Q12866 EXPRESSION TAG SEQADV 5K0X SER B 562 UNP Q12866 EXPRESSION TAG SEQADV 5K0X SER B 563 UNP Q12866 EXPRESSION TAG SEQADV 5K0X GLY B 564 UNP Q12866 EXPRESSION TAG SEQADV 5K0X LEU B 565 UNP Q12866 EXPRESSION TAG SEQADV 5K0X VAL B 566 UNP Q12866 EXPRESSION TAG SEQADV 5K0X PRO B 567 UNP Q12866 EXPRESSION TAG SEQADV 5K0X ARG B 568 UNP Q12866 EXPRESSION TAG SEQADV 5K0X GLY B 569 UNP Q12866 EXPRESSION TAG SEQRES 1 A 313 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 313 LEU VAL PRO ARG GLY SER GLU GLU LEU GLN ASN LYS LEU SEQRES 3 A 313 GLU ASP VAL VAL ILE ASP ARG ASN LEU LEU ILE LEU GLY SEQRES 4 A 313 LYS ILE LEU GLY GLU GLY GLU PHE GLY SER VAL MET GLU SEQRES 5 A 313 GLY ASN LEU LYS GLN GLU ASP GLY THR SER LEU LYS VAL SEQRES 6 A 313 ALA VAL LYS THR MET LYS LEU ASP ASN SER SER GLN ARG SEQRES 7 A 313 GLU ILE GLU GLU PHE LEU SER GLU ALA ALA CYS MET LYS SEQRES 8 A 313 ASP PHE SER HIS PRO ASN VAL ILE ARG LEU LEU GLY VAL SEQRES 9 A 313 CYS ILE GLU MET SER SER GLN GLY ILE PRO LYS PRO MET SEQRES 10 A 313 VAL ILE LEU PRO PHE MET LYS TYR GLY ASP LEU HIS THR SEQRES 11 A 313 TYR LEU LEU TYR SER ARG LEU GLU THR GLY PRO LYS HIS SEQRES 12 A 313 ILE PRO LEU GLN THR LEU LEU LYS PHE MET VAL ASP ILE SEQRES 13 A 313 ALA LEU GLY MET GLU TYR LEU SER ASN ARG ASN PHE LEU SEQRES 14 A 313 HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU ARG ASP SEQRES 15 A 313 ASP MET THR VAL CYS VAL ALA ASP PHE GLY LEU SER LYS SEQRES 16 A 313 LYS ILE TYR SER GLY ASP TYR TYR ARG GLN GLY ARG ILE SEQRES 17 A 313 ALA LYS MET PRO VAL LYS TRP ILE ALA ILE GLU SER LEU SEQRES 18 A 313 ALA ASP ARG VAL TYR THR SER LYS SER ASP VAL TRP ALA SEQRES 19 A 313 PHE GLY VAL THR MET TRP GLU ILE ALA THR ARG GLY MET SEQRES 20 A 313 THR PRO TYR PRO GLY VAL GLN ASN HIS GLU MET TYR ASP SEQRES 21 A 313 TYR LEU LEU HIS GLY HIS ARG LEU LYS GLN PRO GLU ASP SEQRES 22 A 313 CYS LEU ASP GLU LEU TYR GLU ILE MET TYR SER CYS TRP SEQRES 23 A 313 ARG THR ASP PRO LEU ASP ARG PRO THR PHE SER VAL LEU SEQRES 24 A 313 ARG LEU GLN LEU GLU LYS LEU LEU GLU SER LEU PRO ASP SEQRES 25 A 313 VAL SEQRES 1 B 313 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 313 LEU VAL PRO ARG GLY SER GLU GLU LEU GLN ASN LYS LEU SEQRES 3 B 313 GLU ASP VAL VAL ILE ASP ARG ASN LEU LEU ILE LEU GLY SEQRES 4 B 313 LYS ILE LEU GLY GLU GLY GLU PHE GLY SER VAL MET GLU SEQRES 5 B 313 GLY ASN LEU LYS GLN GLU ASP GLY THR SER LEU LYS VAL SEQRES 6 B 313 ALA VAL LYS THR MET LYS LEU ASP ASN SER SER GLN ARG SEQRES 7 B 313 GLU ILE GLU GLU PHE LEU SER GLU ALA ALA CYS MET LYS SEQRES 8 B 313 ASP PHE SER HIS PRO ASN VAL ILE ARG LEU LEU GLY VAL SEQRES 9 B 313 CYS ILE GLU MET SER SER GLN GLY ILE PRO LYS PRO MET SEQRES 10 B 313 VAL ILE LEU PRO PHE MET LYS TYR GLY ASP LEU HIS THR SEQRES 11 B 313 TYR LEU LEU TYR SER ARG LEU GLU THR GLY PRO LYS HIS SEQRES 12 B 313 ILE PRO LEU GLN THR LEU LEU LYS PHE MET VAL ASP ILE SEQRES 13 B 313 ALA LEU GLY MET GLU TYR LEU SER ASN ARG ASN PHE LEU SEQRES 14 B 313 HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU ARG ASP SEQRES 15 B 313 ASP MET THR VAL CYS VAL ALA ASP PHE GLY LEU SER LYS SEQRES 16 B 313 LYS ILE TYR SER GLY ASP TYR TYR ARG GLN GLY ARG ILE SEQRES 17 B 313 ALA LYS MET PRO VAL LYS TRP ILE ALA ILE GLU SER LEU SEQRES 18 B 313 ALA ASP ARG VAL TYR THR SER LYS SER ASP VAL TRP ALA SEQRES 19 B 313 PHE GLY VAL THR MET TRP GLU ILE ALA THR ARG GLY MET SEQRES 20 B 313 THR PRO TYR PRO GLY VAL GLN ASN HIS GLU MET TYR ASP SEQRES 21 B 313 TYR LEU LEU HIS GLY HIS ARG LEU LYS GLN PRO GLU ASP SEQRES 22 B 313 CYS LEU ASP GLU LEU TYR GLU ILE MET TYR SER CYS TRP SEQRES 23 B 313 ARG THR ASP PRO LEU ASP ARG PRO THR PHE SER VAL LEU SEQRES 24 B 313 ARG LEU GLN LEU GLU LYS LEU LEU GLU SER LEU PRO ASP SEQRES 25 B 313 VAL HET CL A 901 1 HET CL A 902 1 HET CL A 903 1 HET K0X A 904 68 HET CL B 901 1 HET CL B 902 1 HET K0X B 903 68 HETNAM CL CHLORIDE ION HETNAM K0X (7S)-7-AMINO-N-[(4-FLUOROPHENYL)METHYL]-8-OXO-2,9,16, HETNAM 2 K0X 18,21-PENTAAZABICYCLO[15.3.1]HENICOSA-1(21),17,19- HETNAM 3 K0X TRIENE-20-CARBOXAMIDE HETSYN K0X UNC2541 FORMUL 3 CL 5(CL 1-) FORMUL 6 K0X 2(C24 H34 F N7 O2) FORMUL 10 HOH *95(H2 O) HELIX 1 AA1 ASP A 583 ASN A 585 5 3 HELIX 2 AA2 SER A 636 ASP A 643 1 8 HELIX 3 AA3 ASP A 678 SER A 686 1 9 HELIX 4 AA4 PRO A 696 ARG A 717 1 22 HELIX 5 AA5 ALA A 725 ARG A 727 5 3 HELIX 6 AA6 PRO A 763 ILE A 767 5 5 HELIX 7 AA7 ALA A 768 ASP A 774 1 7 HELIX 8 AA8 THR A 778 THR A 795 1 18 HELIX 9 AA9 GLN A 805 HIS A 807 5 3 HELIX 10 AB1 GLU A 808 HIS A 815 1 8 HELIX 11 AB2 LEU A 826 CYS A 836 1 11 HELIX 12 AB3 ASP A 840 ARG A 844 5 5 HELIX 13 AB4 THR A 846 SER A 860 1 15 HELIX 14 AB5 ASN B 575 ASP B 579 5 5 HELIX 15 AB6 ASP B 583 ASN B 585 5 3 HELIX 16 AB7 PHE B 634 PHE B 644 1 11 HELIX 17 AB8 ASP B 678 SER B 686 1 9 HELIX 18 AB9 PRO B 696 ARG B 717 1 22 HELIX 19 AC1 ALA B 725 ARG B 727 5 3 HELIX 20 AC2 PRO B 763 ILE B 767 5 5 HELIX 21 AC3 ALA B 768 ASP B 774 1 7 HELIX 22 AC4 THR B 778 THR B 795 1 18 HELIX 23 AC5 GLN B 805 HIS B 807 5 3 HELIX 24 AC6 GLU B 808 HIS B 815 1 8 HELIX 25 AC7 LEU B 826 CYS B 836 1 11 HELIX 26 AC8 ASP B 840 ARG B 844 5 5 HELIX 27 AC9 THR B 846 SER B 860 1 15 SHEET 1 AA1 5 LEU A 587 GLY A 594 0 SHEET 2 AA1 5 VAL A 601 LYS A 607 -1 O VAL A 601 N LEU A 593 SHEET 3 AA1 5 SER A 613 THR A 620 -1 O LEU A 614 N LEU A 606 SHEET 4 AA1 5 PRO A 667 PRO A 672 -1 O LEU A 671 N ALA A 617 SHEET 5 AA1 5 GLY A 654 ILE A 657 -1 N GLY A 654 O ILE A 670 SHEET 1 AA2 2 CYS A 729 LEU A 731 0 SHEET 2 AA2 2 VAL A 737 VAL A 739 -1 O CYS A 738 N MET A 730 SHEET 1 AA3 5 LEU B 587 GLY B 594 0 SHEET 2 AA3 5 VAL B 601 LYS B 607 -1 O GLU B 603 N GLY B 590 SHEET 3 AA3 5 SER B 613 LYS B 619 -1 O VAL B 616 N GLY B 604 SHEET 4 AA3 5 PRO B 665 PRO B 672 -1 O LEU B 671 N ALA B 617 SHEET 5 AA3 5 GLY B 654 MET B 659 -1 N GLU B 658 O LYS B 666 SHEET 1 AA4 2 CYS B 729 LEU B 731 0 SHEET 2 AA4 2 VAL B 737 VAL B 739 -1 O CYS B 738 N MET B 730 SITE 1 AC1 2 ARG A 584 LEU A 589 SITE 1 AC2 2 PRO A 802 LYS A 820 SITE 1 AC3 3 ARG A 687 MET B 798 HOH B1036 SITE 1 AC4 10 LEU A 593 ALA A 617 PRO A 672 PHE A 673 SITE 2 AC4 10 MET A 674 LYS A 675 ARG A 727 ASN A 728 SITE 3 AC4 10 MET A 730 ASP A 741 SITE 1 AC5 3 PRO B 802 LYS B 820 HOH B1016 SITE 1 AC6 4 ARG B 584 LEU B 587 ILE B 588 LEU B 589 SITE 1 AC7 8 LEU B 593 ALA B 617 PRO B 672 MET B 674 SITE 2 AC7 8 LYS B 675 ARG B 727 ASN B 728 MET B 730 CRYST1 51.671 91.599 69.769 90.00 102.37 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019353 0.000000 0.004244 0.00000 SCALE2 0.000000 0.010917 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014674 0.00000